270
Views
0
CrossRef citations to date
0
Altmetric
Review

Drug delivery systems for wound healing treatment of upper airway injury

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 573-591 | Received 27 Oct 2023, Accepted 04 Apr 2024, Published online: 10 Apr 2024

References

  • Durbin CG Jr., Bell CT, Shilling AM. Elective intubation. Respir Care. 2014 Jun;59(6):825–849. discussion 847-9. doi: 10.4187/respcare.02802
  • Nadeem AUR, Gazmuri RJ, Waheed I, et al. Adherence to evidence-base endotracheal intubation practice patterns by intensivists and emergency department physicians. J Acute Med. 2017 Jun 1;7(2):47–53. doi: 10.6705/j.jacme.2017.0702.001
  • Lovett PB, Flaxman A, Sturmann KM, et al. The insecure airway: a comparison of knots and commercial devices for securing endotracheal tubes. BMC Emerg Med. 2006 May 24;6(1):7. doi: 10.1186/1471-227X-6-7
  • Cairns CK. National hospital ambulatory medical care survey: 2020 emergency department summary tables. National Center for Health Statistic (U.S.), CDC Stacks Public Health Publications; 2020. https://stacks.cdc.gov/pap
  • Parish AJ, West JR, Caputo ND, et al. Early intubation and increased coronavirus disease 2019 mortality: a propensity score-matched retrospective cohort study. Crit Care Explor. 2021 Jun;3(6):e0452.
  • Hillel AT, Karatayli-Ozgursoy S, Samad I, et al. Predictors of posterior glottic stenosis: a multi-institutional case-control study. Ann Otol Rhinol Laryngol. 2016 Mar;125(3):257–263.
  • Katsantonis N-G, Kabagambe EK, Wootten CT, et al. Height is an independent risk factor for postintubation laryngeal injury. Laryngoscope. 2018;128(12):2811–2814. doi: 10.1002/lary.27237
  • Zhang Z. Mechanics of human voice production and control. J Acoust Soc Am. 2016 Oct;140(4):2614. doi: 10.1121/1.4964509
  • Jiang J, Lin E, Hanson DG. Vocal fold physiology. Otolaryngol Clin North Am. 2000 Aug;33(4):699–718. doi: 10.1016/S0030-6665(05)70238-3
  • Benninger MS, Alessi D, Archer S, et al. Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg. 1996 Nov;115(5):474–482.
  • Pacheco-Lopez PC, Berkow LC, Hillel AT, et al. Complications of airway management. Respir Care. 2014 Jun;59(6):1006–1021. discussion 1019-21. doi: 10.4187/respcare.02884
  • Tsukamoto M, Taura S, Hitosugi T, et al. A case of laryngeal granulomas after oral and maxillofacial surgery with prolonged intubation. Anesth Prog. 2021 Jun 1;68(2):94–97. doi: 10.2344/anpr-68-01-03
  • Martins RHG, Dias NH, Soares CSP, et al. Treatment of laryngeal granulomas. Int Arch Otorhinolaryngol. 2019 Jul;23(3):e322–e324.
  • Tikka T, Hilmi OJ. Upper airway tract complications of endotracheal intubation. Br J Hosp Med. 2019 Aug 2;80(8):441–447. doi: 10.12968/hmed.2019.80.8.441
  • Brodsky MB, Levy MJ, Jedlanek E, et al. Laryngeal Injury and upper airway symptoms after oral endotracheal intubation with mechanical ventilation during critical care: a systematic review. Crit Care Med. 2018 Dec;46(12):2010–2017.
  • Brodsky MB, Akst LM, Jedlanek E, et al. Laryngeal Injury and upper airway symptoms after endotracheal intubation during surgery: a systematic review and meta-analysis. Anesth Analg. 2021 Apr 1;132(4):1023–1032. doi: 10.1213/ANE.0000000000005276
  • Rafii B, Sridharan S, Taliercio S, et al. Glucocorticoids in laryngology: a review. Laryngoscope. 2014 Jul;124(7):1668–1673.
  • Govil N, Rafii BY, Paul BC, et al. Glucocorticoids for vocal fold disease: a survey of otolaryngologists. J Voice. 2014 Jan;28(1):82–87. doi: 10.1016/j.jvoice.2013.04.015
  • Lorenz RR. Adult laryngotracheal stenosis: etiology and surgical management. Curr Opin Otolaryngol Head Neck Surg. 2003 Dec;11(6):467–472. doi: 10.1097/00020840-200312000-00011
  • Wright CD, Li S, Geller AD, et al. Postintubation tracheal stenosis: management and results 1993 to 2017. Ann Thorac Surg. 2019 Nov;108(5):1471–1477.
  • Franco RA, Husain I, Reder L, et al. Awake serial intralesional steroid injections without surgery as a novel targeted treatment for idiopathic subglottic stenosis. Laryngoscope. 2018;128(3):610–617. doi: 10.1002/lary.26874
  • Cohen SM, Kim J, Roy N, et al. Direct health care costs of laryngeal diseases and disorders. Laryngoscope. 2012 Jul;122(7):1582–1588.
  • Wang CT, Lai MS, Cheng PW. Long-term surveillance following intralesional steroid injection for benign vocal fold lesions. JAMA Otolaryngology Head & Neck Surg. 2017 Jun 1;143(6):589–594. doi: 10.1001/jamaoto.2016.4418
  • Yin LX, Padula WV, Gadkaree S, et al. Health care costs and cost-effectiveness in laryngotracheal stenosis. Otolaryngol Head Neck Surg. 2019 Apr;160(4):679–686.
  • Kitahara S, Masuda Y, Kitagawa Y. Vocal fold injury following endotracheal intubation. J Laryngol Otol. 2005 Oct;119(10):825–827. doi: 10.1258/002221505774481192
  • Imaizumi M, Nakamura R, Nakaegawa Y, et al. Regenerative potential of basic fibroblast growth factor contained in biodegradable gelatin hydrogel microspheres applied following vocal fold injury: early effect on tissue repair in a rabbit model. Braz J Otorhinolaryngol. 2021 May;87(3):274–282.
  • Young WG, Hoffman MR, Koszewski IJ, et al. Voice outcomes following a single office-based steroid injection for vocal fold scar. Otolaryngol Head Neck Surg. 2016 Nov;155(5):820–828.
  • Pena J, Cicero R, Marin J, et al. Laryngotracheal reconstruction in subglottic stenosis: an ancient problem still present. Otolaryngol Head Neck Surg. 2001 Oct;125(4):397–400.
  • Koshkareva Y, Gaughan JP, Soliman AM. Risk factors for adult laryngotracheal stenosis: a review of 74 cases. Ann Otol Rhinol Laryngol. 2007 Mar;116(3):206–210. doi: 10.1177/000348940711600308
  • Davis RJ, Hillel AT. Inflammatory pathways in the pathogenesis of iatrogenic laryngotracheal stenosis: what do we know? Transl Cancer Res. 2020;9(3):2108–2116. doi: 10.21037/tcr.2020.01.21
  • Dorris ER, Russell J, Murphy M. Post-intubation subglottic stenosis: aetiology at the cellular and molecular level. Eur Respir Rev. 2021;30(159):200218. doi: 10.1183/16000617.0218-2020
  • Chang E, Wu L, Masters J, et al. Iatrogenic subglottic tracheal stenosis after tracheostomy and endotracheal intubation: a cohort observational study of more severity in keloid phenotype. Acta Anaesthesiol Scand. 2019 Aug;63(7):905–912.
  • Aibara S, Okada M, Tanaka-Nishikubo K, et al. Laryngeal complications after endotracheal intubation and prone positioning in patients with coronavirus disease 2019. Laryngoscope Investig Otolaryngol. 2022 Dec;7(6):1909–1914.
  • Çomunoğlu N, Batur Ş, Mine Önenerk A. Pathology of nonneoplastic lesions of the vocal folds. Voice And Swallowing Disorders. 2019. https://www.semanticscholar.org/paper/Pathology-of-Nonneoplastic-Lesions-of-the-Vocal-%C3%87omuno%C4%9Flu-Batur/051529c2f365e9015fb369ac31989a05ac6f357f
  • Jacobson BH, Johnson A, Grywalski C, et al. The voice handicap index (VHI). Am J Speech Lang Pathol. 1997;6(3):66–70. doi: 10.1044/1058-0360.0603.66
  • Biddle AK, Watson LR, Hooper CR, et al. Criteria for determining disability in speech-language disorders. Evid Rep Technol Assess (Summ). 2002 Jan;52:1–4.
  • Rosen CA, Lee AS, Osborne J, et al. Development and validation of the voice handicap index-10. Laryngoscope. 2004 Sep;114(9):1549–1556.
  • Hirano M. Clinical examination of voice. Vienna: Springer-Verlag; 1981. https://archive.org/details/clinicalexaminat0000hira
  • Solomon NP, Garlitz SJ, Milbrath RL. Respiratory and laryngeal contributions to maximum phonation duration. J Voice. 2000 Sep;14(3):331–340. doi: 10.1016/S0892-1997(00)80079-X
  • Barsties VLB, Watts CR, Neumann K. The effectiveness of voice therapy on voice-related handicap: a network meta-analysis. Clin Otolaryngol. 2020 Sep;45(5):796–804. doi: 10.1111/coa.13596
  • Latoszek BV, Watts CR, Schwan K, et al. The maximum phonation time as marker for voice treatment efficacy: a network meta‐analysis. Clin Otolaryngol. 2022;48(2):130–138. doi: 10.1111/coa.14019
  • Song SA, Sandhu G, Franco RA. Should we routinely use pulmonary function testing in the management of subglottic stenosis? Laryngoscope. 2020;131(2):245–247. doi: 10.1002/lary.28678
  • Bhatt NK, Huang VP, Bertelsen C, et al. Pulmonary function tests may better predict dyspnea-severity in patients with subglottic stenosis compared to clinician-reported stenosis. Ann Otol Rhinol Laryngol. 2022 Jul;131(7):791–796.
  • Woo P. Quantification of videostrobolaryngoscopic findings – measurements of the normal glottal cycle. Laryngoscope. 1996 Mar;106(Suppl S79):1–27. doi: 10.1097/00005537-199603001-00001
  • Woo P. Objective measures of laryngeal imaging: what have we learned since Dr. Paul Moore. Journal Of Voice. 2014;28(1):69–81. doi: 10.1016/j.jvoice.2013.02.001
  • Svec JG, Schutte HK. Videokymography: high-speed line scanning of vocal fold vibration. J Voice. 1996 Jun;10(2):201–205. doi: 10.1016/S0892-1997(96)80047-6
  • Dion GR, Guda T, Mukudai S, et al. Quantifying vocal fold wound-healing biomechanical property changes. Laryngoscope. 2020 Feb;130(2):454–459. doi: 10.1002/lary.27999
  • Tran QT, Berke GS, Gerratt BR, et al. Measurement of Young’s modulus in the in vivo human vocal folds. Ann Otol Rhinol Laryngol. 1993 Aug;102(8):584–591.
  • Tanaka S, Hirano M. Fiberscopic estimation of vocal fold stiffness in vivo using the sucking method. Arch Otolaryngol Head Neck Surg. 1990 Jun;116(6):721–724. doi: 10.1001/archotol.1990.01870060079015
  • Hsiao TY, Wang CL, Chen CN, et al. Elasticity of human vocal folds measured in vivo using color Doppler imaging. Ultrasound Med Biol. 2002 Sep;28(9):1145–1152.
  • Kniesburges S, Thomson SL, Barney A, et al. In vitro experimental investigation of voice production. Curr Bioinform. 2011 Sep 1;6(3):305–322. doi: 10.2174/157489311796904637
  • Dion GR, Lavoie JF, Coelho P, et al. Automated indentation mapping of vocal fold structure and cover properties across species. Laryngoscope. 2019 Jan;129(1):E26–E31.
  • Dion GR, Jeswani S, Roof S, et al. Functional assessment of the ex vivo vocal folds through biomechanical testing: A review. Mater Sci Eng C. 2016;64:444–453. doi: 10.1016/j.msec.2016.04.018
  • Dion GR, Coelho PG, Teng S, et al. Dynamic nanomechanical analysis of the vocal fold structure in excised larynges. Laryngoscope. 2017 Jul;127(7):E225–E230.
  • Mortensen M. Laryngeal steroid injection for vocal fold scar. Curr Opin Otolaryngol Head Neck Surg. 2010 Dec;18(6):487–491. doi: 10.1097/MOO.0b013e32833fe112
  • Hillel AT, Lin LM, Samlan R, et al. Inhaled triamcinolone with proton pump inhibitor for treatment of vocal process granulomas: a series of 67 granulomas. Ann Otol Rhinol Laryngol. 2010 May;119(5):325–330.
  • Campagnolo AM, Tsuji DH, Sennes LU, et al. Histologic study of acute vocal fold wound healing after corticosteroid injection in a rabbit model. Ann Otol Rhinol Laryngol. 2010 Feb;119(2):133–139.
  • Amin MR, Achlatis S, Gherson S, et al. The role of oral steroids in the treatment of phonotraumatic vocal fold lesions in women. Otolaryngol Head Neck Surg. 2019 Mar;160(3):512–518.
  • Wang CT, Lai MS, Hsiao TY. Comprehensive outcome researches of intralesional steroid injection on benign vocal fold lesions. J Voice. 2015 Sep;29(5):578–587. doi: 10.1016/j.jvoice.2014.11.002
  • Rahbar R, Shapshay SM, Healy GB. Mitomycin: effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol. 2001 Jan;110(1):1–6. doi: 10.1177/000348940111000101
  • Fawaz SA, Sabri SM, Sweed AS, et al. Use of local mitomycin C in enhancing laryngeal healing after laser cordotomy: a prospective controlled study. Head Neck. 2014 Sep;36(9):1248–1252.
  • Feinstein AJ, Goel A, Raghavan G, et al. Endoscopic management of subglottic stenosis. JAMA Otolaryngology Head & Neck Surg. 2017 May 1;143(5):500–505. doi: 10.1001/jamaoto.2016.4131
  • Montes-Worboys A, Gilabert-Porres J, Lopez-Lisbona R, et al. Effect of paclitaxel delivered nanoparticles to treat tracheal stenosis. 1.4 interventional pulmonology. Eur Respir J. 2015;46:PA4870.
  • Qiu X-J, Zhang J, Wang J, et al. Application of paclitaxel as adjuvant treatment for benign cicatricial airway stenosis. J Huazhong Univ Sci Technol Med Sci. 2016;36(6):817–822. doi: 10.1007/s11596-016-1668-6
  • Rosow DE, Ahmed J. Initial experience with low-dose methotrexate as an adjuvant treatment for rapidly recurrent nonvasculitic laryngotracheal stenosis. JAMA Otolaryngology Head & Neck Surg. 2017;143(2):125. doi: 10.1001/jamaoto.2016.2895
  • Kanazawa T, Komazawa D, Indo K, et al. Single injection of basic fibroblast growth factor to treat severe vocal fold lesions and vocal fold paralysis. Laryngoscope. 2015 Oct;125(10):E338–44.
  • Ban MJ, Park JH, Kim JW, et al. The efficacy of fibroblast growth factor for the treatment of chronic vocal fold scarring: from animal model to clinical application. Clin Exp Otorhinolaryngol. 2017 Dec;10(4):349–356.
  • Hirano S, Sugiyama Y, Kaneko M, et al. Intracordal injection of basic fibroblast growth factor in 100 cases of vocal fold atrophy and scar. Laryngoscope. 2021 Sep;131(9):2059–2064.
  • Nozawa M, Takahashi S, Kanazawa T, et al. Intracordal injection therapy for vocal fold scarring: Steroid versus basic fibroblast growth factor. Laryngoscope Investig Otolaryngol. 2022 Oct;7(5):1465–1473.
  • Wingstrand VL, Gronhoj Larsen C, Jensen DH, et al. Mesenchymal stem cell therapy for the treatment of vocal fold scarring: a systematic review of preclinical studies. PLOS ONE. 2016;11(9):e0162349. doi: 10.1371/journal.pone.0162349
  • Jakobsen KK, Gronhoj C, Jensen DH, et al. Mesenchymal stem cell therapy for laryngotracheal stenosis: a systematic review of preclinical studies. PLOS ONE. 2017;12(9):e0185283. doi: 10.1371/journal.pone.0185283
  • Hertegard S, Nagubothu SR, Malmstrom E, et al. Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells-first phase I/II human clinical study. Stem Cell Res Ther. 2020 Mar 20;11(1):128. doi: 10.1186/s13287-020-01632-8
  • Kodama H, Kumai Y, Nishimoto K, et al. Potential treatment for vocal fold scar with pirfenidone. Laryngoscope. 2018 May;128(5):E171–E177.
  • Turkmen E, Pata YS. Prevention of tracheal stenosis with pirfenidone after tracheotomy: an experimental study. Laryngoscope. 2019 May;129(5):E178–E186. doi: 10.1002/lary.27704
  • Li X, Pan J, Qian H, et al. Treatment of scarring central airway stenosis with pirfenidone: case report. Medicine (Baltimore). 2022 Oct 28;101(43):e31354. doi: 10.1097/MD.0000000000031354
  • Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun. 1997;239(3):639–644. doi: 10.1006/bbrc.1997.7517
  • Hirano S, Bless DM, Rousseau B, et al. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope. 2004 Mar;114(3):548–556.
  • Luo Y, Kobler JB, Zeitels SM, et al. Effects of growth factors on extracellular matrix production by vocal Fold fibroblasts in 3-dimensional culture. Tissue Eng. 2006;12(12):3365–3374. doi: 10.1089/ten.2006.12.3365
  • Kishimoto Y, Hirano S, Suehiro A, et al. Effect of exogenous hepatocyte growth factor on vocal fold fibroblasts. Ann Otol Rhinol Laryngol. 2009 Aug;118(8):606–611.
  • Mizuta M, Hirano S, Kishimoto Y, et al. Pharmacokinetics and safety of human recombinant hepatocyte growth factor administered to vocal folds. Laryngoscope. 2014 Sep;124(9):2131–2135.
  • Kolachala VL, Henriquez OA, Shams S, et al. Slow-release nanoparticle-encapsulated delivery system for laryngeal injection. Laryngoscope. 2010 May;120(5):988–994. doi: 10.1002/lary.20856
  • Choi JS, Heang Oh S, Kim YM, et al. Hyaluronic acid/alginate hydrogel containing hepatocyte growth factor and promotion of vocal fold wound healing. Tissue Eng Regen Med. 2020 Oct;17(5):651–658.
  • Dillard DG, Gal AA, Roman-Rodriguez J, et al. Transforming growth factor and neutralizing antibodies in subglottic stenosis. Ann Otol Rhinol Laryngol. 2001 May;110(5):393–400.
  • Simpson CB, White S, McGuff HS. Anti-transforming growth factor beta as a treatment for laryngotracheal stenosis in a canine model. Laryngoscope. 2008 Mar;118(3):546–551. doi: 10.1097/MLG.0b013e31815daf6e
  • Wei P, Huang Z, Gan L, et al. Nintedanib ameliorates tracheal stenosis by activating HDAC2 and suppressing IL-8 and VEGF in rabbit. Am J Transl Res. 2020;12(8):4739–4748.
  • Fan Y, Li X, Fang X, et al. Antifibrotic role of nintedanib in tracheal stenosis after a tracheal wound. Laryngoscope. 2021 Sep;131(9):E2496–E2505.
  • Friedrich M, Aigner A. Therapeutic siRNA: state-of-the-art and future perspectives. BioDrugs. 2022 Sep;36(5):549–571. doi: 10.1007/s40259-022-00549-3
  • Paul BC, Rafii BY, Gandonu S, et al. Smad3: an emerging target for vocal fold fibrosis. Laryngoscope. 2014 Oct;124(10):2327–2331.
  • Ito S, Nagata K. Biology of Hsp47 (Serpin H1), a collagen-specific molecular chaperone. Semin Cell Dev Biol. 2017 Feb;62:142–151. doi: 10.1016/j.semcdb.2016.11.005
  • Hiwatashi N, Kraja I, Benedict PA, et al. Nanoparticle delivery of RNA-based therapeutics to alter the vocal fold tissue response to injury. Laryngoscope. 2018 May;128(5):E178–E183.
  • Mukudai S, Kraja I, Bing R, et al. Implementing efficient peptoid-mediated delivery of RNA-based therapeutics to the vocal folds. Laryngoscope Investig Otolaryngol. 2019 Dec;4(6):640–644.
  • Kishimoto Y, Yamashita M, Wei A, et al. Reversal of vocal fold mucosal fibrosis using siRNA against the collagen-specific chaperone serpinh1. Mol Ther Nucleic Acids 2019 Jun 7;16:616–625. doi: 10.1016/j.omtn.2019.04.014
  • Shlomi D, Peled N, Shitrit D, et al. Protective effect of immunosuppression on granulation tissue formation in metallic airway stents. Laryngoscope. 2008 Aug;118(8):1383–1388.
  • Mizokami D, Araki K, Tanaka N, et al. Tacrolimus prevents laryngotracheal stenosis in an acute-injury rat model. Laryngoscope. 2015 Jun;125(6):E210–5.
  • Namba DR, Ma G, Samad I, et al. Rapamycin inhibits human laryngotracheal stenosis-derived fibroblast proliferation, metabolism, and function in vitro. Otolaryngol Head Neck Surg. 2015 May;152(5):881–888.
  • Duvvuri M, Motz K, Murphy M, et al. Engineering an immunomodulatory drug-eluting stent to treat laryngotracheal stenosis. Biomater Sci. 2019 Apr 23;7(5):1863–1874. doi: 10.1039/C8BM01623B
  • You BR, Park WH. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion. Oncol Rep. 2012 Aug;28(2):749–757. doi: 10.3892/or.2012.1852
  • Luo F, Zhuang Y, Sides MD, et al. Arsenic trioxide inhibits transforming growth factor-beta1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo. Respir Res. 2014 Apr 24;15(1):51. doi: 10.1186/1465-9921-15-51
  • Zhong L, Hao H, Chen D, et al. Arsenic trioxide inhibits the differentiation of fibroblasts to myofibroblasts through nuclear factor erythroid 2‐like 2 (NFE2L2) protein and the Smad2/3 pathway. J Cell Physiol. 2018;234(3):2606–2617. doi: 10.1002/jcp.27073
  • Li Y, Li M, Wang X, et al. Arsenic trioxide-eluting electrospun nanofiber-covered self-expandable metallic stent reduces granulation tissue hyperplasia in rabbit trachea. Biomed Mater. 2020 Dec 16;16(1):015013. doi: 10.1088/1748-605X/abb25a
  • Nakazono-Kusaba A, Takahashi-Yanaga F, Morimoto S, et al. Staurosporine-induced cleavage of alpha-smooth muscle actin during myofibroblast apoptosis. J Invest Dermatol. 2002 Nov;119(5):1008–1013.
  • Xu H, Wang Q, Fan GK. The antiproliferative and antifibrotic effects of cisplatin on primary human vocal fold fibroblasts. ORL J Otorhinolaryngol Relat Spec. 2020;82(4):188–200. doi: 10.1159/000506708
  • Li Z, Tian C, Jiao D, et al. Synergistic effects of silver nanoparticles and cisplatin in combating inflammation and hyperplasia of airway stents. Bioact Mater. 2022 Mar;9:266–280. doi: 10.1016/j.bioactmat.2021.07.029
  • Lamparter S, Slight SH, Weber KT. Doxycycline and tissue repair in rats. J Lab Clin Med. 2002 May;139(5):295–302. doi: 10.1067/mlc.2002.122624
  • Baskaran R, Ko UJ, Davaa E, et al. Doxycycline-eluting core-shell type nanofiber-covered trachea stent for inhibition of cellular metalloproteinase and its related fibrotic stenosis. Pharmaceutics. 2019 Aug 19;11(8):421. doi: 10.3390/pharmaceutics11080421
  • Choi JS, Kim JM, Kim JW, et al. Prevention of tracheal inflammation and fibrosis using nitinol stent coated with doxycycline. Laryngoscope. 2018 Jul;128(7):1558–1563.
  • Kim HS, Yoon YM, Meang MK, et al. Reversion of in vivo fibrogenesis by novel chromone scaffolds. EBioMedicine. 2019 Jan;39:484–496. doi: 10.1016/j.ebiom.2018.12.017
  • Park SJ, Choi H, Kim JH, et al. Antifibrotic effects of eupatilin on TGF-beta1-treated human vocal fold fibroblasts. PLOS ONE. 2021;16(3):e0249041. doi: 10.1371/journal.pone.0249041
  • Yao Y, Zhou Y, Liu L, et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci. 2020;7:193. doi: 10.3389/fmolb.2020.00193
  • Ohno T, Hirano S, Kanemaru S, et al. Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol. 2007 Oct;116(10):762–769.
  • Erndt-Marino JD, Jimenez-Vergara AC, Diaz-Rodriguez P, et al. In vitro evaluation of a basic fibroblast growth factor-containing hydrogel toward vocal fold lamina propria scar treatment. J Biomed Mater Res B Appl Biomater. 2018 Apr;106(3):1258–1267.
  • Kosinski AM, Pothen JM, Panitch A, et al. Dexamethasone controlled release on tgf-beta1 treated vocal fold fibroblasts. Ann Otol Rhinol Laryngol. 2015 Jul;124(7):572–578.
  • Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arabian J Chem. 2019;12(7):908–931. doi: 10.1016/j.arabjc.2017.05.011
  • Auffan M, Rose J, Bottero JY, et al. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotech. 2009 Oct;4(10):634–641.
  • Baig N, Kammakakam I, Falath W. Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges. Mater Adv. 2021;2(6):1821–1871. doi: 10.1039/D0MA00807A
  • Kopecek J. Hydrogels: from soft contact lenses and implants to self-assembled nanomaterials. J Polym Sci A Polym Chem. 2009 Nov 15;47(22):5929–5946. doi: 10.1002/pola.23607
  • Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev. 2008 Dec 14;60(15):1638–1649. doi: 10.1016/j.addr.2008.08.002
  • Li J, Mooney DJ. Designing hydrogels for controlled drug delivery. Nat Rev Mater. 2016 Dec;1(12). doi: 10.1038/natrevmats.2016.71
  • Hoare TR, Kohane DS. Hydrogels in drug delivery: progress and challenges. Polymer. 2008;49(8):1993–2007. doi: 10.1016/j.polymer.2008.01.027
  • Gerecht S, Burdick JA, Ferreira LS, et al. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA. 2007 Jul 3;104(27):11298–11303. doi: 10.1073/pnas.0703723104
  • Kim YM, Oh SH, Choi JS, et al. Adipose-derived stem cell-containing hyaluronic acid/alginate hydrogel improves vocal fold wound healing. Laryngoscope. 2014 Mar;124(3):E64–72.
  • Kobayashi T, Mizuta M, Hiwatashi N, et al. Drug delivery system of basic fibroblast growth factor using gelatin hydrogel for restoration of acute vocal fold scar. Auris Nasus Larynx. 2017 Feb;44(1):86–92.
  • Murata H, Chang BJ, Prucker O, et al. Polymeric coatings for biomedical devices. Surf Sci. 2004;570(1–2):111–118. doi: 10.1016/j.susc.2004.06.185
  • Qiang Wei RH, Haag R. Universal polymer coatings and their representative biomedical applications. Mater Horizons. 2015;2(6):567–577. doi: 10.1039/C5MH00089K
  • Nathanael AJ, Oh TH. Biopolymer coatings for biomedical applications. Polymers. 2020;12(12):3061. doi: 10.3390/polym12123061
  • Johnson CM, Luke AS, Jacobsen C, et al. State of the science in tracheal stents: a scoping review. Laryngoscope. 2022 Nov;132(11):2111–2123.
  • Wahidi MM, Ernst A. The Montgomery T-tube tracheal stent. Clin Chest Med. 2003 Sep;24(3):437–443. doi: 10.1016/S0272-5231(03)00042-X
  • Fortin M, Lacasse Y, Elharrar X, et al. Safety and efficacy of a fully covered self-expandable metallic stent in benign airway stenosis. Respiration. 2017;93(6):430–435. doi: 10.1159/000472155
  • Chen DF, Chen Y, Zhong CH, et al. Long-term efficacy and safety of the Dumon stent for benign tracheal stenosis: a meta-analysis. J Thorac Dis. 2021 Jan;13(1):82–91.
  • Gompelmann D, Eberhardt R, Schuhmann M, et al. Self-expanding Y stents in the treatment of central airway stenosis: a retrospective analysis. Ther Adv Respir Dis. 2013 Oct;7(5):255–263.
  • Terrier B, Dechartres A, Girard C, et al. Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience. Rheumatology (Oxford). 2015 Oct;54(10):1852–1857. doi: 10.1093/rheumatology/kev129
  • Sindeeva OA, Prikhozhdenko ES, Schurov I, et al. Patterned drug-eluting coatings for tracheal stents based on PLA, PLGA, and PCL for the granulation formation reduction: in vivo studies. Pharmaceutics. 2021 Sep 9;13(9):1437. doi: 10.3390/pharmaceutics13091437
  • Zhu GH, Ng AH, Venkatraman SS, et al. A novel bioabsorbable drug-eluting tracheal stent. Laryngoscope. 2011 Oct;121(10):2234–2239.
  • Chao YK, Liu KS, Wang YC, et al. Biodegradable cisplatin-eluting tracheal stent for malignant airway obstruction: in vivo and in vitro studies. Chest. 2013 Jul;144(1):193–199.
  • Haas CF, Eakin RM, Konkle MA, et al. Endotracheal tubes: old and new. Respir Care. 2014 Jun;59(6):933–955. doi: 10.4187/respcare.02868
  • Abu Ammar A, Gruber M, Martin P, et al. Local delivery of mometasone furoate from an eluting endotracheal tube. J Control Release. 2018 Feb 28;272:54–61. doi: 10.1016/j.jconrel.2018.01.005
  • Jahshan F, Abu Ammar A, Ertracht O, et al. Local delivery of mometasone furoate from an eluting endotracheal tube reduces airway morbidity following long-term animal intubation. ACS Appl Bio Mater. 2021 May 17;4(5):4131–4139. doi: 10.1021/acsabm.0c01526
  • Malka R, Gonzales G, Detar W, et al. Effect of continuous local dexamethasone on tissue biomechanics and histology after inhalational burn in a preclinical model. Laryngoscope Investig Oto. 2023;8(4):939–945. doi: 10.1002/lio2.1093
  • Hazekamp MG, Nijdam N. Use of autologous arterial patches for tracheal reconstruction in young infants. Ann Thorac Surg. 2004 Jun;77(6):2262–2263. doi: 10.1016/j.athoracsur.2003.06.027
  • Anton-Pacheco JL, Morante R. Operative or non-operative treatment of congenital tracheal stenosis: is there something new? J Thorac Dis. 2017 Dec;9(12):4878–4880. doi: 10.21037/jtd.2017.11.75
  • Miar S, Dion GR, Montelongo S, et al. Development of a bioinspired, self-adhering, and drug-eluting laryngotracheal patch. Laryngoscope. 2021 Sep;131(9):1958–1966.
  • Zheng A, Waterkotte T, Debele T, et al. Biodegradable dexamethasone polymer capsule for long-term release. Korean J Chem Eng. 2023;40(2):452–460. doi: 10.1007/s11814-022-1358-y

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.